Literature DB >> 7012015

Factors influencing release of type III antigens by group B streptococci.

T I Doran, D C Straus, S J Mattingly.   

Abstract

The release of serotype III group B streptococcal polysaccharides into the supernatant fluid was examined under a variety of physiological conditions. Release of both high- and low-molecular-weight type III antigens was fairly constant throughout exponential growth, but increased markedly upon entering the stationary phase of growth. Increased glucose and decreased phosphate concentrations both caused a large increase in release of antigens. Inhibition of protein synthesis in exponentially growing cells by chloramphenicol (10 micrograms/ml) caused a condition of unbalanced growth in which antigen release was increased greatly over control values. Strain variability in antigen release was also observed. Strains which are known to be high neuraminidase producers released elevated levels of both low- and high-molecular-weight type III antigens. Non-neuraminidase-producing strains released considerably less high-molecular-weight antigen, but similar levels of the low-molecular-weight antigen compared with the high neuraminidase producers. Strain D136C, a type III non-neuraminidase producer, released negligible quantities of the high-molecular-weight antigen in the supernatant fluid. These results indicate that both the physiological environment and the type III strain are important in determining the quantity of type-specific antigen released into the culture fluid.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7012015      PMCID: PMC351353          DOI: 10.1128/iai.31.2.615-623.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Rapid diagnosis of type III group B streptococcal meningitis by latex particle agglutination.

Authors:  M S Edwards; D L Kasper; C J Baker
Journal:  J Pediatr       Date:  1979-08       Impact factor: 4.406

2.  Growth and amino acid requirements of various strains of group B streptococci.

Authors:  T W Milligan; T I Doran; D C Straus; S J Mattingly
Journal:  J Clin Microbiol       Date:  1978-01       Impact factor: 5.948

3.  Type-specific polysaccharide antigens of group B streptococci.

Authors:  R C Lancefield; E H Freimer
Journal:  J Hyg (Lond)       Date:  1966-06

4.  Immunochemistry of purified polysaccharide type antigens of group B streptococcal types Ia, Ib, and Ic.

Authors:  H W Wilkinson
Journal:  Infect Immun       Date:  1975-04       Impact factor: 3.441

5.  Identification of sialic acid in polysaccharide antigens in group B Streptococcus.

Authors:  C J Baker; D L Kasper
Journal:  Infect Immun       Date:  1976-01       Impact factor: 3.441

6.  Detection of group B streptococcal antibodies in human sera by radioimmunoassay: concentrations of type-specific antibodies in sera of adults and infants infected with group B streptococci.

Authors:  H W Wilkinson
Journal:  J Clin Microbiol       Date:  1978-02       Impact factor: 5.948

7.  Type-specific antigens of group B type Ic streptococci.

Authors:  H W Wilkinson; R G Eagon
Journal:  Infect Immun       Date:  1971-11       Impact factor: 3.441

8.  Soluble group- and type-specific antigens from type III group B Streptococcus.

Authors:  R B Carey; T K Eisenstein; G D Shockman; T F Greber; R M Swenson
Journal:  Infect Immun       Date:  1980-04       Impact factor: 3.441

9.  Countercurrent immunoelectrophoresis in the evaluation of infants with group B streptococcal disease.

Authors:  C J Baker; B J Webb; C V Jackson; M S Edwards
Journal:  Pediatrics       Date:  1980-06       Impact factor: 7.124

10.  Isolation of type-specific polysaccharide antigen from group B type Ib streptococci.

Authors:  J Y Tai; E C Gotschlich; R C Lancefield
Journal:  J Exp Med       Date:  1979-01-01       Impact factor: 14.307

View more
  18 in total

1.  High-virulence clone of group B streptococci unable to grow at high temperatures is present in serotypes other than type III.

Authors:  Gerardo C Palacios; Maria N Gonzalez; Magdalena Beltran; Jose L Arredondo; Javier Torres; Fortino Solorzano
Journal:  Curr Microbiol       Date:  2006-12-13       Impact factor: 2.188

2.  Emergence of novel Streptococcus iniae exopolysaccharide-producing strains following vaccination with nonproducing strains.

Authors:  Marina Eyngor; Yoram Tekoah; Roni Shapira; Avshalom Hurvitz; Amir Zlotkin; Avishay Lublin; Avi Eldar
Journal:  Appl Environ Microbiol       Date:  2008-09-19       Impact factor: 4.792

3.  Decreased capacity for type-specific-antigen synthesis accounts for high prevalence of nontypeable strains of group B streptococci in Mexico.

Authors:  G C Palacios; E K Eskew; F Solorzano; S J Mattingly
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

4.  Possible virulence marker for Streptococcus agalactiae (Lancefield Group B).

Authors:  G Orefici; S Recchia; L Galante
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-04       Impact factor: 3.267

5.  Biosynthesis of cell wall peptidoglycan and polysaccharide antigens by protoplasts of type III group B Streptococcus.

Authors:  M K Yeung; S J Mattingly
Journal:  J Bacteriol       Date:  1983-04       Impact factor: 3.490

6.  Biosynthetic capacity for type-specific antigen synthesis determines the virulence of serotype III strains of group B streptococci.

Authors:  M K Yeung; S J Mattingly
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

7.  Association of type- and group-specific antigens with the cell wall of serotype III group B streptococcus.

Authors:  T I Doran; S J Mattingly
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

8.  Type-specific capsular antigen is associated with virulence in late-onset group B Streptococcal type III disease.

Authors:  M E Klegerman; K M Boyer; C K Papierniak; L Levine; S P Gotoff
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

9.  Identification of a high-virulence clone of type III Streptococcus agalactiae (group B Streptococcus) causing invasive neonatal disease.

Authors:  J M Musser; S J Mattingly; R Quentin; A Goudeau; R K Selander
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

10.  Teichoic acids of Streptococcus agalactiae: chemistry, cytotoxicity, and effect on bacterial adherence to human cells in tissue culture.

Authors:  J C Goldschmidt; C Panos
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.